539206
GVBL
Invest Now
Start SIP in
GVBL
Performance
- Low
- ₹47
- High
- ₹48
- 52 Week Low
- ₹40
- 52 Week High
- ₹108
- Open Price₹47
- Previous Close₹49
- Volume1,627
Investment Returns
- Over 1 Month + 1.27%
- Over 3 Month -23.07%
- Over 6 Month -35.1%
- Over 1 Year -4.06%
Smart Investing Starts Here Start SIP with Genomic Valley Biotech for Steady Growth!
Genomic Valley Biotech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 42
- PEG Ratio
- 0
- Market Cap Cr
- 15
- P/B Ratio
- 3.7
- Average True Range
- 2.75
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.34
- RSI
- 47.54
- MFI
- 41.21
Genomic Valley Biotech Financials
Genomic Valley Biotech Technicals
EMA & SMA
Current Price
₹47.75
-1.24
(-2.53%)

-
- Bearish Moving Average 16
-
- Bullish Moving Average 0
- 20 Day
- ₹49.47
- 50 Day
- ₹51.28
- 100 Day
- ₹55.46
- 200 Day
- ₹58.68
Resistance and Support
48.17
- R3 52.33
- R2 50.67
- R1 49.83
- S1 47.33
- S2 45.67
- S3 44.83
Genomic Valley Biotech Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-05-30 | Audited Results | |
2025-02-14 | Quarterly Results | |
2024-12-06 | Others | Inter alia - To consider and Approve (1) The Directors Report for the Year 2023-24. (2) 30th AGM of the Company and Other Business Matters. |
2024-10-07 | Quarterly Results | |
2024-07-29 | Quarterly Results |
Genomic Valley Biotech F&O
About Genomic Valley Biotech
- NSE Symbol
- GVBL
- BSE Symbol
- 539206
- Managing Director
- Mr. Yogesh Agrawal
- ISIN
- INE574D01010
Similar Stocks to Genomic Valley Biotech
Genomic Valley Biotech FAQs
Genomic Valley Biotech share price is ₹47 As on 16 July, 2025 | 09:46
The Market Cap of Genomic Valley Biotech is ₹14.6 Cr As on 16 July, 2025 | 09:46
The P/E ratio of Genomic Valley Biotech is 42 As on 16 July, 2025 | 09:46
The PB ratio of Genomic Valley Biotech is 3.7 As on 16 July, 2025 | 09:46
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.